UNLABELLED: Intra-hepatic metastasis is one of the major modalities that lead to the recurrence of advanced HCC. Research efforts to investigate HCC metastasis/recurrence and therapy response will require appropriate models. For our study, the main purpose was to compare two different rodent syngenic orthotopic HCC models using MRI and pathologic evidence; we specifically sought to investigate the intra-hepatic metastatic properties of HCC in Buffalo rats. METHODS: 12 female Buffalo rats and 16 male Sprague Dawley (SD) rats were used in these studies. Subcapsular implantation of 1×10(6) McA-RH7777 and 1×10(6) N1-S1 rat hepatoma cells into the left hepatic lobe was carried out in Buffalo and SD rats, respectively. Buffalo hepatoma rats (n=5/6) and SD hepatoma rats (n=6/8) were imaged using MRI at 6-8 days after implantation. Then, another group of Buffalo HCC rats (n=6/6) and SD HCC (n=6/8) rats were scanned at 21-25 days interval post-implantation. After image acquisition, tumor sections were evaluated with H&E and CD34 staining. RESULTS: Tumor induction rate for Buffalo rats was 92% (11/12) compared to 75% (12/16) for SD rats. The mean tumor size of McA-RH7777 hepatoma rats at 6-8 day interval was 1.32±0.56cm, but progressed to multiple intra-hepatic metastasis at 21-25 day interval in 6/6 rats (100%). In contrast, the mean tumor size of N1-S1 rats at early interval was 1.06±0.32cm, these progressed to only a single solid mass of 2.35±0.69cm at later interval without obvious intra-hepatic metastasis. H&E staining showed that McA-RH7777 cell induced Morris hepatoma exhibited typical trabecular growth pattern, better representative of human HCC compared to the sheet pattern of N1-S1 cell induced Novikoff hepatoma. CONCLUSION: The McA-Rh7777 rat hepatoma model was demonstrated to be a highly malignant intra-hepatic metastasis model of potential utility for HCC research.
UNLABELLED: Intra-hepatic metastasis is one of the major modalities that lead to the recurrence of advanced HCC. Research efforts to investigate HCC metastasis/recurrence and therapy response will require appropriate models. For our study, the main purpose was to compare two different rodent syngenic orthotopic HCC models using MRI and pathologic evidence; we specifically sought to investigate the intra-hepatic metastatic properties of HCC in Buffalo rats. METHODS: 12 female Buffalo rats and 16 male Sprague Dawley (SD) rats were used in these studies. Subcapsular implantation of 1×10(6) McA-RH7777 and 1×10(6) N1-S1 rathepatoma cells into the left hepatic lobe was carried out in Buffalo and SDrats, respectively. Buffalo hepatomarats (n=5/6) and SD hepatomarats (n=6/8) were imaged using MRI at 6-8 days after implantation. Then, another group of Buffalo HCC rats (n=6/6) and SD HCC (n=6/8) rats were scanned at 21-25 days interval post-implantation. After image acquisition, tumor sections were evaluated with H&E and CD34 staining. RESULTS:Tumor induction rate for Buffalo rats was 92% (11/12) compared to 75% (12/16) for SDrats. The mean tumor size of McA-RH7777 hepatomarats at 6-8 day interval was 1.32±0.56cm, but progressed to multiple intra-hepatic metastasis at 21-25 day interval in 6/6 rats (100%). In contrast, the mean tumor size of N1-S1 rats at early interval was 1.06±0.32cm, these progressed to only a single solid mass of 2.35±0.69cm at later interval without obvious intra-hepatic metastasis. H&E staining showed that McA-RH7777 cell induced Morris hepatoma exhibited typical trabecular growth pattern, better representative of human HCC compared to the sheet pattern of N1-S1 cell induced Novikoff hepatoma. CONCLUSION: The McA-Rh7777 rathepatoma model was demonstrated to be a highly malignant intra-hepatic metastasis model of potential utility for HCC research.
Entities:
Keywords:
Hepatocellular carcinoma (HCC); MRI; McARH7777 rat HCC cell line; N1-S1 rat HCC cell line; histopathology; orthotopic implantation; rodent model
Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: T Ogawa; H Tashiro; Y Miyata; Y Ushitora; Y Fudaba; T Kobayashi; K Arihiro; M Okajima; T Asahara Journal: Am J Transplant Date: 2007-01-04 Impact factor: 8.086
Authors: Wooram Park; Andrew C Gordon; Soojeong Cho; Xiaoke Huang; Kathleen R Harris; Andrew C Larson; Dong-Hyun Kim Journal: ACS Appl Mater Interfaces Date: 2017-04-17 Impact factor: 9.229
Authors: Samdeep K Mouli; Patrick Tyler; Joseph L McDevitt; Aaron C Eifler; Yang Guo; Jodi Nicolai; Robert J Lewandowski; Weiguo Li; Daniel Procissi; Robert K Ryu; Y Andrew Wang; Riad Salem; Andrew C Larson; Reed A Omary Journal: ACS Nano Date: 2013-08-20 Impact factor: 15.881
Authors: Joseph L McDevitt; Samdeep K Mouli; Patrick D Tyler; Weiguo Li; Jodi Nicolai; Daniele Procissi; Ann B Ragin; Y Andrew Wang; Robert J Lewandowski; Riad Salem; Andrew C Larson; Reed A Omary Journal: J Vasc Interv Radiol Date: 2014-05-20 Impact factor: 3.464
Authors: Sarah B White; Dong-Hyun Kim; Yang Guo; Weiguo Li; Yihe Yang; Jeane Chen; Venkateswara R Gogineni; Andrew C Larson Journal: Radiology Date: 2017-07-13 Impact factor: 11.105
Authors: Scott M Thompson; Matthew R Callstrom; Bruce Knudsen; Jill L Anderson; Rickey E Carter; Joseph P Grande; Lewis R Roberts; David A Woodrum Journal: J Vasc Interv Radiol Date: 2012-01-20 Impact factor: 3.464
Authors: Su Jung Ham; YoonSeok Choi; Seul-I Lee; Jinil Kim; Young Il Kim; Jin Wook Chung; Kyung Won Kim Journal: Hepatol Int Date: 2017-07-18 Impact factor: 6.047